Maine Medicine Weekly Update - 07/16/2021  (Plain Text Version)

Return to Graphical Version

 

In this issue:
•  Promoting COVID-19 Vaccination in Clinical Settings: The Critical Role of Maine’s Physicians
•  A Call to Action- Protecting the Children of Maine
•  COVID News: Surgeon Gener Surgeon General Issues Vaccine Misinformation Warning; JAMA Peds Retracts Masks Study
•  Johnson & Johnson Recalls Sunscreens After Carcinogen Found
•  Opioid & Substance Use Disorder News
•  Medicare Updates
•  Federal Advocacy Update
•  Registration Open for MMA’s 168th Annual Membership Meeting (Sep 10-12)
•  Notice of Rulemaking: Immunization requirements for Maine school children
•  Maine Secretary of State Seeking Physician Volunteers
•  SUPPORT for ME: Strengthening Substance Use Disorder Treatment and Recovery Services for MaineCare Members
•  Are You a Professional Who Works with Individuals in Maine Who Have a Substance Use Disorder? We Want to Hear From You!
•  Maine Community Action Partnership: Did You Know?
•  MMA Mary Cushman, MD Award for Humanitarian Service
UPCOMING EVENTS
•  Upcoming Specialty Society Meetings
•  AAP EQIPP Course: Immunizations - Strategies for Success (for RURAL Health Providers)
•  SUPPORT for ME Training and Technical Assistance Initiative
•  Working with Children & Adolescents? Maine Pediatric & Behavioral Health Partnership (MPBHP) Webinar Series (July thru December 2nd Wednesday of month)
• 
• 
• 
HEALTHCARE EMPLOYMENT OPPORTUNITIES
•  Physician (BC/BE in Family Medicine) - Strong Area Health Center
•  Physician (BC/BE in Family Medicine) - Richmond Area Health Center
•  Help educate new physicians – join our accredited Family Medicine Residency Program as faculty
•  Join our region-leading Neuroscience/Stroke Center
•  Contract Clinical Advisor - Healthcare Coalition of Maine
•  Medical Director

 

Medicare Updates

  • Medicare Proposes 2022 Payment and Quality Reporting Changes
  • Medicare to Weigh Nationwide Coverage Rules for Biogen Alzheimer's Drug

  • Medicare Proposes 2022 Payment and Quality Reporting Changes
  • Medicare to Weigh Nationwide Coverage Rules for Biogen Alzheimer's Drug

Medicare Proposes 2022 Payment and Quality Reporting Changes

The Centers for Medicare & Medicaid Services (CMS) released the proposed 2022 Medicare physician fee schedule (PFS) rule this week, which includes proposed changes to the Merit-based Incentive Payment System (MIPS) and alternative payment model (APM) participation options and requirements for 2022.

The changes include a decrease in the "conversion factor" -- the multiplier that Medicare applies to relative value units (RVUs) to calculate reimbursement for a particular service or procedure under Medicare's fee-for-service system.

·      CMS Fact Sheet – Physician Fee Schedule (webpage)

·      CMS Fact Sheet – Quality Payment Program (PDF download)

·      CMS Fact Sheet – Medicare Diabetes Prevention Program (webpage)

·      Complete CY 2022 Physician Fee Schedule and Quality Payment Program proposed rule.

CMS is accepting comments on the proposed rule until September 13.

Medicare to Weigh Nationwide Coverage Rules for Biogen Alzheimer's Drug

CMS will formally consider whether to adopt nationwide rules for coverage of Biogen's new Alzheimer's drug Aduhelm, announcing Monday the opening of a determination process that could shape how millions of Americans are able to access the controversial treatment. (Healthcare Dive)